↓ Skip to main content

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma

Overview of attention for article published in this source, August 2011
Altmetric Badge

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
53 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma
Published by
John Wiley & Sons, Ltd, August 2011
DOI 10.1002/14651858.cd007941.pub2
Pubmed ID
Authors

Bauer, Kathrin, Skoetz, Nicole, Monsef, Ina, Engert, Andreas, Brillant, Corinne

Abstract

There are two different international standards for the treatment of early unfavourable and advanced stage Hodgkin lymphoma (HL): chemotherapy with escalated BEACOPP (bleomycin/etoposide/doxorubicin/cyclophosphamide/vincristine/procarbazine/prednisone) regimen and chemotherapy with ABVD (doxorubicin/bleomycin/vinblastine/dacarbazine) regimen.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 2%
Unknown 52 98%

Demographic breakdown

Readers by professional status Count As %
Other 7 13%
Researcher 6 11%
Student > Ph. D. Student 6 11%
Student > Master 5 9%
Student > Bachelor 5 9%
Other 11 21%
Unknown 13 25%
Readers by discipline Count As %
Medicine and Dentistry 22 42%
Pharmacology, Toxicology and Pharmaceutical Science 5 9%
Biochemistry, Genetics and Molecular Biology 3 6%
Agricultural and Biological Sciences 2 4%
Philosophy 1 2%
Other 4 8%
Unknown 16 30%